Company
Technology Platform
Products
Services
Resources
News & Events
Contact Us
More
News
September 25, 2019
NeuCyte and REPROCELL enter distribution agreement in North America and Europe
September 24, 2019
NeuCyte licenses promising novel compound for treatment of refractory epilepsy and related neurological disorders
December 3, 2018
NeuCyte outlicenses its novel neuronal programming technology
May 8, 2018
NeuCyte completes Series A financing
Events
Sept. 29 - Oct. 3, 2019
NeuCyte presents at the International Neurotoxicity Association Meeting in Düsseldorf, Germany
September 23-26, 2019
July 24-26, 2019
June 17-20, 2019
March 10-14, 2019
NeuCyte exhibits at the Safety Pharmacology Society Annual Meeting
NeuCyte presents at the Precision Medicine Ion Channel Retreat
NeuCyte exhibits and presents at the World Preclinical in Boston, MA
NeuCyte exhibits and presents at the SOT (Society of Toxicology) Annual Meeting
Go to Archive